EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis

So Yon Jun iD, Sooyoung Cho, Min Jung Kim, Ji Won Park iD, Seung-Bum Ryoo iD, Seung Yong Jeong, Kyu Joo Park, Aesun Shin iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von So Yon Jun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventative Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical diabetic traits have been reported to be associated with increased colorectal cancer (CRC) risk in observational studies. Using the Mendelian randomization (MR) analysis method, we examined the causal association between glycemic traits, such as fasting glucose (FG), fasting insulin (FI), and glycosylated hemoglobin A1c (HbA1c), and survival in a cohort of CRC patients.

Methods

We conducted a two‐sample MR analysis among a cohort of patients with locally advanced CRC at Seoul National University Hospital. Single‐nucleotide polymorphisms robustly associated ( p < 5 × 10 −8 ) with the three glycemic traits were obtained from the Meta‐Analyses of Glucose and Insulin‐related traits Consortium, Asian Genetic Epidemiology Network, and Korea Biobank Array. Three‐year and 5‐year overall survival (OS) and progression‐free survival (PFS) were used as outcomes. Survival analysis was conducted using subgroup analysis by cancer stage and subsite in a multivariate Cox proportional hazards model adjusted for age and sex to examine whether glycemic traits affected survival.

Results

A total of 509 patients were included in our final analysis. MR analysis showed that HbA1c levels were associated with poor 3‐year OS ( β = 4.20, p = 0.02). Sensitivity analyses did not show evidence of any violations of the MR assumptions. In the cancer subgroup analysis of the Cox proportional hazards model, pooled hazard ratios for FG were significantly associated with poor 3‐year OS and PFS regardless of cancer stage. FI was not significantly associated with any 3‐year survival endpoints. Among Stage III patients, three glycemic traits were significantly associated with both 5‐year OS and PFS. Location‐specific subgroup analysis showed a significant association between three glycemic traits and 5‐year PFS in patients with left‐sided colon cancer. FG was associated with poor 3‐year survival for colon cancer but not rectal cancer.

Conclusions

Our results suggest that FG and HbA1c could be used to predict prognosis in CRC patients. Lifestyle and/or pharmacological interventions targeting glycemic traits could help improve survival for CRC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsColonic NeoplasmsDiabetes Mellitus, Type 2HumansGlycated HemoglobinBlood GlucoseMendelian Randomization AnalysisInsulinRepublic of KoreaGlucosePolymorphism, Single NucleotideGenome-Wide Association Study

Stichwörter der Autor:innen

Mendelian randomization analysisType 2 diabetescolorectal cancerglycemic traits

Substanzen

Glycated HemoglobinBlood GlucoseInsulinGlucose

Autor:innen und Institutionen

  • Department of Preventative Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, South Korea.

ORCID-Profile: So Yon Jun, Ji Won Park, Seung-Bum Ryoo, Aesun Shin

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Jun, S. Y., Cho, S., Kim, M. J., Park, J. W., Ryoo, S. B., Jeong, S. Y., Park, K. J., & Shin, A. (2024). Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis. Cancer Medicine. https://doi.org/10.1002/cam4.7084

Vancouver

Jun SY, Cho S, Kim MJ, Park JW, Ryoo SB, Jeong SY, et al. Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis. Cancer Medicine. 2024. doi:10.1002/cam4.7084

BibTeX
@article{Jun2024,
  author = {Jun, So Yon and Cho, Sooyoung and Kim, Min Jung and Park, Ji Won and Ryoo, Seung-Bum and Jeong, Seung Yong and Park, Kyu Joo and Shin, Aesun},
  title = {Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7084}
}
Kostenlos starten →